Article ID Journal Published Year Pages File Type
3198613 Journal of Allergy and Clinical Immunology 2012 8 Pages PDF
Abstract
Treatment with ICS/LABA fixed-dose combination therapy appeared to perform as well as or better than ICS treatment alone in reducing severe asthma exacerbations; this included multiple high-risk subgroups.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population
Authors
, , , , , , , ,